Stephen Seiler is CEO of AesRx, a company he founded in 2009 to develop orphan drugs. Prior to founding AesRx, he was CEO of several public and private biotech companies that he successfully led through restructuring and refinancing and/or trade sales, including Idera Pharmaceuticals, Access Pharmaceuticals and Effective Pharmaceuticals. Before that, Seiler was executive vice president for planning, investment and development at Elan Corp. Read more »
Mr. Ronald Bartek is FARA's Co-founder and President; Chairman of the Board of the National Organization for Rare Disorders (NORD); 4-year member, NIH National Advisory Neurological Disorders and Stroke Council, and former partner and president of a business and technology development, consulting, and government affairs firm. Mr. Read more »
Timothy J. Keeler is a partner in the Government and Global Trade Group at Mayer Brown LLP. Tim previously served as the Chief of Staff of the Office of the U.S. Trade Representative, as a senior official at the US Treasury Department, and on the international trade staff of the Senate Finance Committee.
Tim provides legal and strategic advice to clients on matters including: Read more »
Dorothy is member of Microsoft’s US Government Affairs team in Washington, D.C. and is responsible for leading the company’s policy efforts on international trade and economic issues, focusing on open markets for services and devices. She is an experienced trade negotiator and expert in trade policy, and works on behalf of Microsoft before the Executive Branch, Congress, international organizations and foreign governments. Within the company she supports Microsoft’s subsidiaries on international trade and economic issues. Read more »
David Weller is Head of Global Trade Policy at Google based in Washington, DC. Prior to joining Google in December 2013, he was a partner at WilmerHale, where he advised technology and other clients regarding foreign market access barriers, WTO disputes, and trade policy issues. Read more »